首页> 美国卫生研究院文献>PLoS Clinical Trials >Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal
【2h】

Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal

机译:区域报告,负责对意大利进行的国家以下地方的麻疹消灭监测以及查明实现消灭目标的当地障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although most countries in the WHO European Region were verified in 2017 as having interrupted endemic measles transmission, nine countries were still endemic. Among these, Italy accounted for the second highest number of measles cases reported in Europe in 2017. The elimination of measles is verified at national level by each country’s National Verification Committee (NVC) through the production of an Annual Status Update (ASU). Since in Italy decentralization has led to an inhomogeneous implementation of immunization strategies among the 21 administrative Regions, the Italian NVC proposed that measles elimination should also be documented at the subnational level through regional ASUs and Synthetic Regional Reports (SRRs). The regional ASUs and the SRRs for 2014, 2015 and 2016 were produced and appraised by the NVC to evaluate the Regions’ performances in each individual year as well as over the whole period. A specific analysis of vaccination coverage, including official immunization data for 2017, was performed. Moreover, the measles epidemic of 2017 was examined. Firstly, in the period 2014–2016, low immunization rates were registered in most Regions. Sixty-three per cent of southern Regions reported rates below the national mean and an overall low-quality performance. The approval of Italy’s mandatory vaccination law in 2017 resulted in a marked increase in vaccination coverage; however, this increase was not homogeneous among Regions. Secondly, more than 50% of Regions did not report any supplemental immunization activity (SIA) for the period 2014–2016. Thirdly, from 2014 to 2016, fewer than one-third of Regions improved their reporting of outbreaks. Finally, over the study period, only two Regions reached the target required by the WHO for measles laboratory investigations. In countries with decentralized health policies, subnational monitoring can help identify local barriers to measles elimination. In Italy it has highlighted the need for further SIAs and a stronger surveillance system.
机译:尽管2017年世卫组织欧洲区域的大多数国家都被证实已经中断了地方性麻疹传播,但仍有9个国家仍是地方性麻疹。其中,意大利是2017年欧洲报告的麻疹病例第二高的国家。每个国家的国家验证委员会(NVC)通过制作年度状态更新(ASU)在国家一级对麻疹的消除进行了验证。由于在意大利的权力下放导致了21个行政区域中免疫策略的实施不均匀,因此意大利NVC提议应通过地区ASU和综合地区报告(SRR)在国家以下各级记录消除麻疹的情况。 NVC制作并评估了2014年,2015年和2016年的地区ASU和SRR,以评估该地区在每年以及整个期间的绩效。进行了疫苗接种覆盖率的具体分析,包括2017年的官方免疫数据。此外,还检查了2017年的麻疹流行情况。首先,在2014-2016年期间,大多数地区的免疫接种率较低。南部地区的百分之六十三报告的比率低于全国平均水平,并且总体表现不佳。意大利于2017年批准了强制性疫苗接种法,疫苗接种覆盖率显着增加;但是,各地区之间的增长并不均匀。其次,超过50%的地区在2014-2016年期间未报告任何补充免疫活动(SIA)。第三,从2014年到2016年,不到三分之一的地区改善了疫情报告。最后,在研究期内,只有两个区域达到了世界卫生组织对麻疹实验室调查所要求的目标。在卫生政策分散的国家中,国家以下监测可以帮助确定当地消除麻疹的障碍。在意大利,它强调了需要进一步的SIA和更强大的监视系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号